BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 19, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Sep. 18, 2006
View Archived Issues
Vertex Raises $300M In Year's Second Largest Public Offering
It is the opinion of many biotech executives that the best time to raise money is when you don't need it. (BioWorld Today)
Read More
CepTor Eyeing Ferring's SOD Drug For Neonatal Application
Read More
New Group Formed To Seek Better Base Funding For FDA
Read More
New Science, Cash Strength Helped Amicus To Still More
Read More
Other News To Note
Read More
Appointments And Advancements
Read More